CASE 1-2008 - One institution's decreasing use of aprotinin during cardiac surgery in 2006

被引:3
作者
Strouch, Zaneta Y. [1 ]
Chaney, Mark A. [1 ]
Augoustides, John G. T. [2 ]
Spiess, Bruce D. [3 ]
机构
[1] Univ Chicago, Med Ctr, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA
[2] Hosp Univ Penn, Dept Anesthesiol & Crit Care, Cardiothorac & Vasc Sect, Philadelphia, PA 19104 USA
[3] Virginia Commonwealth Univ, Med Ctr, Dept Anesthesiol & Emergency Med, Richmond, VA USA
关键词
cardiac surgery; aprotinin; blood-product use;
D O I
10.1053/j.jvca.2007.11.005
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:139 / 146
页数:8
相关论文
共 42 条
[1]   Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trial [J].
Alderman, EL ;
Levy, JH ;
Rich, JB ;
Nili, M ;
Vidne, B ;
Schaff, H ;
Uretzky, G ;
Pettersson, G ;
Thiis, JJ ;
Hantler, CB ;
Chaitman, B ;
Nadel, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (05) :716-729
[2]  
*AM CANC SOC, POSS RISKS BLOOD PRO
[3]   Risk index for perioperative renal dysfunction/failure - Critical dependence on pulse pressure hypertension [J].
Aronson, Solomon ;
Fontes, Manuel L. ;
Miao, Yinghui ;
Mangano, Dennis T. .
CIRCULATION, 2007, 115 (06) :733-742
[4]   Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass [J].
Augoustides, John G. T. .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2007, 21 (02) :302-304
[5]   Transfusion increases the risk of postoperative infection after cardiovascular surgery [J].
Banbury, MK ;
Brizzio, ME ;
Rajeswaran, J ;
Lytle, BW ;
Blackstone, EH .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) :131-138
[6]   Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery [J].
Brown, Jeremiah R. ;
Birkmeyer, Nancy J. O. ;
O'Connor, Gerald T. .
CIRCULATION, 2007, 115 (22) :2801-2813
[7]   Stroke after cardiac surgery: A risk factor analysis of 16,184 consecutive adult patients [J].
Bucerius, J ;
Gummert, JF ;
Borger, MA ;
Walther, T ;
Doll, N ;
Onnasch, JF ;
Metz, S ;
Falk, V ;
Mohr, FW .
ANNALS OF THORACIC SURGERY, 2003, 75 (02) :472-478
[8]  
CHANEY M, 2006, SOC CARDIOVASCULAR A, V5, P5
[9]   Evaluating the safety implications of aprotinin use: The retrospective evaluation of aprotinin in cardio thoracic surgery (REACTS) [J].
Coleman, Craig I. ;
Rigali, Vera T. ;
Hammond, Jonathan ;
Kluger, Jeffrey ;
Jeleniowski, Kenneth W. ;
White, C. Michael .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (06) :1547-1552
[10]   Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting [J].
DeFoe, GR ;
Ross, CS ;
Olmstead, EM ;
Surgenor, SD ;
Fillinger, MP ;
Groom, RC ;
Forest, RJ ;
Pieroni, JW ;
Warren, CS ;
Bogosian, ME ;
Krumholz, CF ;
Clark, C ;
Clough, RA ;
Weldner, PW ;
Lahey, SJ ;
Leavitt, BJ ;
Marrin, CAS ;
Charlesworth, DC ;
Marshall, P ;
O'Connor, GT .
ANNALS OF THORACIC SURGERY, 2001, 71 (03) :769-776